J&J gets earnings boost from blockbuster psoriasis drug
Sales of Stelara are expected to be $10.54bn in 2024, down 3% from the $10.86bn in 2023
Stay updated with breaking news from Organisation Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sales of Stelara are expected to be $10.54bn in 2024, down 3% from the $10.86bn in 2023
Latest news on Ireland's companies and busines organisations and their impact locally, nationally and globally.
Slowing demand for coronavirus shots will have more significant consequences on J&J’s competitors, Pfizer and Moderna
America's 574 federally recognised Native American tribes and Alaska Native villages experienced higher rates of drug overdose deaths than the national average
People will not be able to choose what vaccine they want, Government warns Ministers say they are aware that the fact that the Johnson & Johnson vaccine is a single dose could lead to frustration as it confers the so-called vaccine bonus much quicker The single-dose Johnson and Johnson vaccine is likely to prove very popular, but government sources said offering people a choice was 'not practical'. Picture: Timothy D Easley, Pool Mon, 12 Apr, 2021 - 06:30 Paul Hosford, Political Correspondent People will not be able to choose what vaccine they want, the Government has warned, as around 14,0...